Essex Bio-Technology Investor Relations Material
Latest events
H1 2025
26 Aug, 2025
H2 2024
26 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Essex Bio-Technology Limited
Access all reports
Essex Bio-Technology Limited is a biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic products. The company focuses on regenerative medicine and specializes in biopharmaceutical drugs for ophthalmology and wound care. Its product portfolio includes formulations derived from recombinant DNA technology and other biological sources. Essex Bio-Technology Limited conducts its operations through integrated facilities that support clinical research, production, and distribution. The company is headquartered in Hong Kong, China, and its shares are listed on the HKEX.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
1061
Country
🇭🇰 Hong Kong